ArticleTargeted oncology2024

Prognostic Impact of HER2-Low and HER2-Zero in Resectable Breast Cancer with Different Hormone Receptor Status: A Landmark Analysis of Real-World Data from the National Cancer Center of China.

Qichen Dai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.